0001127602-19-023019.txt : 20190628
0001127602-19-023019.hdr.sgml : 20190628
20190628161735
ACCESSION NUMBER: 0001127602-19-023019
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190627
FILED AS OF DATE: 20190628
DATE AS OF CHANGE: 20190628
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NABEL ELIZABETH G
CENTRAL INDEX KEY: 0001619929
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38753
FILM NUMBER: 19929635
MAIL ADDRESS:
STREET 1: BRIGHAM AND WOMEN'S HOSPITAL
STREET 2: 75 FRANCIS ST
CITY: BOSTON
STATE: MA
ZIP: 02115
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Moderna, Inc.
CENTRAL INDEX KEY: 0001682852
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 813467528
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6177146500
MAIL ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Moderna Therapeutics, Inc.
DATE OF NAME CHANGE: 20160822
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2019-06-27
0001682852
Moderna, Inc.
MRNA
0001619929
NABEL ELIZABETH G
C/O MODERNA, INC.
200 TECHNOLOGY SQUARE
CAMBRIDGE
MA
02139
1
Stock Option (Right to Buy)
14.34
2019-06-27
4
A
0
54660
0
A
2029-06-27
Common Stock
54660
54660
D
This option will become fully vested and exercisable on the earlier of June 27, 2020, or the next Annual Meeting of Stockholders, subject to the recipient's continued service.
/s/ Jeffrey Cerio, as Attorney-in-Fact
2019-06-28